Search results
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 2 days agoA lackluster efficacy profile isn't mResvia's only downside. Abrysvo and Arexvy don't need to stay...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 2 days agoThe revision follows the approval of Moderna's Respiratory Syncytial Virus (RSV) vaccine by...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 2 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 2 days agoSince mRNA drugs are easily programmable, biotech companies likeModerna are now developing mRNA ...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters via AOL· 6 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
The Boston Globe· 5 days agoModerna said Friday that US drug regulators have approved its second product, a vaccine for...
Scientists are testing mRNA vaccines to protect cows and people against bird flu
Associated Press via Yahoo News· 5 days agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 2 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study ...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 2 days agoThe vaccine, a critical component of Moderna’s pipeline, has bolstered investor confidence following...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 5 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any...